The Goldman Sachs Group Downgrades Fisher & Paykel Healthcare (OTCMKTS:FSPKF) to Neutral

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) was downgraded by equities researchers at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report released on Thursday, The Fly reports.

Shares of FSPKF stock opened at $21.78 on Thursday. The stock has a 50 day moving average of $22.00 and a two-hundred day moving average of $22.26. Fisher & Paykel Healthcare has a 12 month low of $19.61 and a 12 month high of $26.46.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following geographical segments: The New Zealand, North America, Europe, and Asia-Pacific.

Featured Article: Fundamental Analysis

The Fly logo

Receive News & Ratings for Fisher & Paykel Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fisher & Paykel Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.